Group One Trading’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.24M Sell
46,400
-152,200
-77% -$7.1M ﹤0.01% 1973
2025
Q4
$9.62M Buy
198,600
+170,000
+594% +$8.43M 0.02% 987
2025
Q3
$1.35M Buy
28,600
+3,800
+15% +$183K ﹤0.01% 2709
2025
Q2
$1.2M Sell
24,800
-16,900
-41% -$863K ﹤0.01% 2598
2025
Q1
$2.31M Sell
41,700
-1,500
-3% -$81.2K 0.01% 1693
2024
Q4
$2.08M Sell
43,200
-14,000
-24% -$712K ﹤0.01% 1875
2024
Q3
$3.3M Sell
57,200
-180,400
-76% -$9.74M 0.01% 1339
2024
Q2
$11.5M Buy
237,600
+195,300
+462% +$9.42M 0.04% 380
2024
Q1
$2.06M Sell
42,300
-11,300
-21% -$552K 0.01% 1457
2023
Q4
$2.67M Buy
53,600
+22,100
+70% +$1.08M 0.01% 1625
2023
Q3
$1.69M Sell
31,500
-4,200
-12% -$224K 0.01% 1785
2023
Q2
$1.92M Sell
35,700
-23,700
-40% -$1.28M 0.01% 1743
2023
Q1
$3.23M Sell
59,400
-194,100
-77% -$9.44M 0.01% 1143
2022
Q4
$12.3M Buy
253,500
+197,800
+355% +$8.68M 0.03% 619
2022
Q3
$2.12M Buy
55,700
+38,900
+232% +$1.73M ﹤0.01% 1869
2022
Q2
$841K Sell
16,800
-13,700
-45% -$727K ﹤0.01% 2929
2022
Q1
$1.57M Sell
30,500
-115,300
-79% -$5.95M ﹤0.01% 2647
2021
Q4
$7.3M Buy
145,800
+30,800
+27% +$1.52M 0.01% 1377
2021
Q3
$5.54M Buy
115,000
+24,300
+27% +$1.24M 0.01% 1586
2021
Q2
$4.78M Sell
90,700
-8,800
-9% -$459K 0.01% 1731
2021
Q1
$4.92M Sell
99,500
-28,200
-22% -$1.35M 0.01% 1528
2020
Q4
$6.21M Sell
127,700
-11,300
-8% -$557K 0.01% 1132
2020
Q3
$6.97M Sell
139,000
-18,100
-12% -$932K 0.02% 704
2020
Q2
$8.02M Buy
157,100
+64,100
+69% +$3.12M 0.04% 550
2020
Q1
$4.07M Buy
93,000
+69,000
+288% +$3.3M 0.03% 643
2019
Q4
$1.21M Sell
24,000
-1,200
-5% -$56.2K 0.01% 1721
2019
Q3
$1.17M Sell
25,200
-87,000
-78% -$3.75M 0.01% 1619
2019
Q2
$4.86M Buy
112,200
+110,700
+7,380% +$4.71M 0.04% 535
2019
Q1
$66K Buy
1,500
+1,400
+1,400% +$60K ﹤0.01% 3432
2018
Q4
$4K Sell
100
-3,400
-97% -$150K ﹤0.01% 4533
2018
Q3
$156K Sell
3,500
-1,200
-26% -$51.3K ﹤0.01% 3195
2018
Q2
$188K Sell
4,700
-10,100
-68% -$398K ﹤0.01% 3102
2018
Q1
$593K Buy
14,800
+3,900
+36% +$162K 0.01% 1928
2017
Q4
$469K Buy
10,900
+6,900
+173% +$318K ﹤0.01% 2309
2017
Q3
$199K Buy
4,000
+2,300
+135% +$111K ﹤0.01% 2760
2017
Q2
$81K Sell
1,700
-38,600
-96% -$1.84M ﹤0.01% 3248
2017
Q1
$1.82M Buy
40,300
+20,200
+100% +$857K 0.02% 926
2016
Q4
$813K Buy
20,100
+10,600
+112% +$418K 0.01% 1445
2016
Q3
$363K Buy
9,500
+6,800
+252% +$273K ﹤0.01% 2049
2016
Q2
$113K Buy
2,700
+2,300
+575% +$94.3K ﹤0.01% 2783
2016
Q1
$16K Sell
400
-1,500
-79% -$60.3K ﹤0.01% 3855
2015
Q4
$81K Sell
1,900
-1,100
-37% -$50.6K ﹤0.01% 3117
2015
Q3
$142K Buy
3,000
+2,900
+2,900% +$148K ﹤0.01% 2775
2015
Q2
$5K Sell
100
-4,100
-98% -$208K ﹤0.01% 4502
2015
Q1
$208K Sell
4,200
-300
-7% -$14.3K ﹤0.01% 2335
2014
Q4
$205K Buy
+4,500
New +$218K ﹤0.01% 2294

Other funds holding SNY

Group One Trading's SNY Position: Q1 2026 in Review

Group One Trading sold out of Sanofi (SNY) in Q1 2026, closing a stake of 30,430 shares — an estimated $1.42M sold.

Group One Trading first reported a position in SNY in Q4 2017 and held it in 11 quarters. The position peaked at $4.34M in Q4 2021. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Group One Trading reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 30,430 Sanofi shares in Q1 2026, an estimated $1.42M.
  • Group One Trading first reported a position in Sanofi in Q4 2017 and held it in 11 quarters.
  • Group One Trading's Sanofi position peaked at $4.34M in Q4 2021.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.